The isolation, characterization, and bioactivity in the feeding circuitry of a novel neuropeptide in the Aplysia californica central nervous system are reported. The 17-residue amidated peptide, NGGTADALYNLPDLEKIamide, has been termed cerebrin due to its primary location in the cerebral ganglion. Liquid chromatographic puri®cation guided by matrix-assisted laser desorption/ionization time-of-¯ight mass spectrometry allowed the isolation of the peptide with purity adequate for Edman sequencing. The cerebrin cDNA has been characterized and encodes an 86 amino acid prohormone that predicts cerebrin and one additional peptide. Mapping using in situ hybridization and immunocytochemistry showed that cerebrin containing neuronal somata are localized almost exclusively in the cerebral ganglion, mostly in the F-and C-clusters. Both immunostaining and mass spectrometry demonstrated the presence of cerebrin in the neurohemal region of the upper labial nerve. In addition, immunoreactive processes were detected in the neuropil of all of the ganglia, including the buccal ganglia, and in some interganglionic connectives, including the cerebral-buccal connective. This suggests that cerebrin may also function as a local signaling molecule. Cerebrin has a profound effect on the feeding motor pattern elicited by the command-like neuron CBI-2, dramatically shortening the duration of the radula protraction in a concentration-dependent manner, mimicking the motor-pattern alterations observed in food induced arousal states. These ®ndings suggest that cerebrin may contribute to food-induced arousal in the animal. Cerebrin-like immunoreactivity is also present in Lymnaea stagnalis suggesting that cerebrin-like peptides may be widespread throughout gastropoda. Keywords: Aplysia californica, cDNA cloning, in situ hybridization, immunocytochemistry, Lymnaea stagnalis, MALDI MS. Invertebrate model systems are used extensively to gain insight into neural mechanisms that are responsible for the expression and plasticity of behavior. In these systems, characterization of behavior-mediating circuits is greatly facilitated by the fact that neural circuits contain a limited number of neurons. Consequently, in many invertebrates, the neural circuits that mediate a variety of behaviors have been extensively characterized. However, in order to understand the neural basis of behavior it is also necessary to have fairly complete knowledge of signaling molecules that affect the circuits from within and without. Neuropeptides represent the largest and most diverse group of signaling molecules in the nervous system. Advantageous features of invertebrate nervous systems have greatly facilitated identi®cation of neuropeptides that are involved in generating and modifying a number of behaviors. Several important insights into the role of various neuropeptides have been obtained and the functional consequence of the large peptide diversity in several well-de®ned neuronal networks is actively being investigated (Marder et al. 1995; Brezina and Weiss 1997) .
Invertebrate model systems are used extensively to gain insight into neural mechanisms that are responsible for the expression and plasticity of behavior. In these systems, characterization of behavior-mediating circuits is greatly facilitated by the fact that neural circuits contain a limited number of neurons. Consequently, in many invertebrates, the neural circuits that mediate a variety of behaviors have been extensively characterized. However, in order to understand the neural basis of behavior it is also necessary to have fairly complete knowledge of signaling molecules that affect the circuits from within and without. Neuropeptides represent the largest and most diverse group of signaling molecules in the nervous system. Advantageous features of invertebrate nervous systems have greatly facilitated identi®cation of neuropeptides that are involved in generating and modifying a number of behaviors. Several important insights into the role of various neuropeptides have been obtained and the functional consequence of the large peptide diversity in several well-de®ned neuronal networks is actively being investigated (Marder et al. 1995; Brezina and Weiss 1997) .
The feeding circuitry of Aplysia californica is one of the systems in which the contribution of neuropeptides to formation of behavior has been studied extensively.
Numerous studies demonstrated that neuropeptides make important contributions both in the central nervous system (e.g. Sossin et al. 1987; Kirk et al. 1988; Phares and Lloyd 1996; Morgan et al. 2000) and in the periphery (e.g. Lloyd et al. 1984; Cropper et al. 1987a Cropper et al. ,b, 1994 Church et al. 1993; Brezina et al. 1996; Fujisawa et al. 1999) . However, despite signi®cant progress that has been made in identi®ca-tion of important neuropeptides that act on the feeding circuitry, the knowledge of signaling molecules involved in the modulation of this circuitry is far from complete. Recent advances (Li et al. , 2000 in matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS) have greatly facilitated identi®cation and characterization of neuropeptides. Using MALDI MS we have recently characterized a new A. californica peptide, Aplysia insulin (AI, Floyd et al. 1999) . Because AI plays an important role in regulating glucose metabolism and its mRNA level depends on the feeding history of the animal, AI appears to be part of the chemical network that participates in A. californica feeding.
AI is synthesized by the top layer neurons of the F-cluster and is transported to the neurohemal release organs of the upper labial (UL) and anterior tentacular (AT) nerves . Using MALDI MS to pro®le the chemical content of the F-cluster neurons we discovered the presence of a unique mass at 1803 Da in the middle layer neurons (Rubakhin et al. 1999a,b) . This mass also appeared in the neurohemal release organ of the UL nerve, one of the organs thought to be the site of release of AI. The similarity of location of synthesis and putative release sites between AI and the 1803-Da peak suggested that the 1803-Da peptide also participates in feeding behavior of A. californica. Therefore we undertook to determine the nature of the 1803-Da peak and to determine whether it exerts biological activity on the feeding circuitry.
Materials and methods

Animals
A. californica weighing 10±200 g were obtained from Aplysia Research Facility (Miami, FL, USA), while those weighing 200±350 g were purchased from either Paci®c Biomarine (Venice, CA, USA) or Marinus, Inc. (Long Beach, CA, USA) and larger animals (up to 2 kg) were collected from McAbee Beach in Monterey, CA, USA. Paci®c Biomarine also supplied A. vaccaria. Animals were maintained in arti®cial seawater (Instant Ocean; Aquarium Systems, Mentor, OH, USA) at 148C. Adult specimens of L. stagnalis are from a laboratory breed population maintained in the Beckman Institute (Urbana, IL, USA).
MALDI mass spectrometry
For Aplysia, circumesophageal rings as well as buccal and abdominal ganglia with attached connectives were dissected after injection of 390 mm MgCl 2 equal to one-half of each animal's body weight into the vascular cavity. In some cases a moderate protease treatment (e.g. 1% Protease Type IX for 30±60 min at 348C) was used to soften the connective tissues prior to de-sheathing.
Mass spectra were obtained using two mass spectrometers; namely a Voyager Elite and a Voyager DE STR equipped with delayed ion extraction (PE Biosystems, Framingham, MA, USA). A pulsed nitrogen laser (337 nm) was used as the desorption/ ionization source, and positive-ion mass spectra were acquired using both linear and re¯ectron mode. Each representative mass spectrum shown is the unsmoothed average of 64±128 laser pulses. Mass calibration was performed externally using either bovine insulin (Sigma, St Louis, MO, USA) or a previously calibrated spectrum obtained from A. californica bag cells. The averaged mass assignment error is 190 p.p.m. for linear mode, which is typical for the cellular peptide assay using external calibration . Our mass accuracy can be improved several-fold using re¯ectron mode, which requires more concentrated samples and greater instrumental optimization but reduces the mass assignment uncertainty to , 50 p.p.m. The instrumental conditions are optimized individually to produce high quality spectra over the desired mass range so that when examining high mass regions, many peptides at lower masses are not observed (and vice versa). Extracellular salts were removed by a previously described method (Garden et al. 1996) .
Microbore HPLC of homogenates and hemolymph Cerebral F-and C-clusters from 23 animals were pooled for microbore reverse-phase high performance liquid chromatography (HPLC) separation. The clusters were collected on dry-ice and subsequently stored at 2 808C in approximately 200 mL acidi®ed acetone (1 : 40 : 6 HCl : acetone : H 2 O) as described previously . Samples were homogenized in a microhomogenizer (Jencons Scienti®c Ltd, Bedford, UK), sonicated (Branson 2200, Danbury, CT, USA), and centrifuged (Baxter Biofuge 15, McGaw Park, IL, USA). The supernatant was removed, lyophilized (Labconco, Fisher Scienti®c, Itasca, IL, USA), and resuspended in 40 mL of a 2% acetonitrile and 0.1% tri¯uoroacetic acid (TFA) solution. Twenty microliters of the extract was injected in a reversed-phase microbore HPLC instrument (Magic 2002, Michrom BioResources, Auburn, CA, USA) consisting of a Reliasil C-18 column with 300 mm packing. The¯ow-rate was 50 mL/min at ambient temperature. The column was equilibrated with solvent A (see below), and a gradient was developed from 0±80% of solvent B in 30 min and then 80±98% of solvent B in 10 min. The ®rst separation used a 2.0 Â 150 mm C-18 column with solvent A consisting of 2% acetonitrile/,98% H 2 O 1 0.1% TFA and solvent B being 90% acetonitrile/,10% H 2 O 1 0.1% TFA. This resulted in fractions containing multiple coeluting peptides requiring additional separation steps. After each separation, MALDI MS was used to track the peptide of interest through each stage. The fraction containing the 1803-Da peptide was subsequently lyophilized, resuspended in 20 mL of aqueous acetonitrile, and re-injected. For the next stage separation, solvent B was changed to a mixture of isopropanol : acetonitrile : methanol (1 : 2 : 2), with the column changed to 1.0 mm inner diameter (i.d.) C-18, resulting in the collection of a relatively pure fraction containing the novel 1803-Da peptide as observed by MALDI MS.
Approximately 1 L of hemolymph was collected and ®ltered three times through a 1-mm ®lter, reduced to ,100 mL volume under nitrogen¯ow, and loaded onto a series of C-8 Sep-Pak cartridges (Waters, Milford, MA, USA). The cartridges were subsequently rinsed with aliquots of 50% propanol/H 2 O followed by 100% propanol. All eluant was pooled, reduced in volume under nitrogen, and injected onto the HPLC. The separation used a 4.6-mm C-18 column and a¯ow rate of 250 mL/min with the same gradient/solvents as described above. Fractions were collected and subjected to MALDI MS analysis.
In all cases, the samples were collected by a fraction collector (Gilson FC 203B, Middletown, WI, USA). All fractions were screened by MALDI MS; 0.25 mL of each HPLC fraction was deposited onto a MALDI sample plate followed by the same volume of a-cyano-4-hydroxy-cinnamic acid (10 mg/mL, dissolved in 6 : 3 : 1 acetonitrile:water:3% TFA) (Aldrich, Milwaukee, WI, USA) or aqueous dihydroxybenzoic acid (DHB) (ICN Pharmaceuticals, Costa Mesa, CA, USA) (10 mg/mL) matrix solutions. Unless otherwise speci®ed all solvents were purchased from Fisher Scienti®c and were reagent quality or better.
Cloning
The cDNA encoding the cerebrin precursor was cloned using previously described methods Fujisawa et al. 1999) . Standard molecular techniques (Sambrook et al. 1989) were used except where noted. A. californica cDNA library was a gift of Dr Gregg Nagle. The library, a directional University of-Zap Lambda phage library (Stratagene, La Jolla, CA, USA), was used both as a template for PCR and for conventional hybridization screening. Semi-nested degenerate RACE was performed using two vector primers and an antisense degenerate primer designed to a subset of the peptide sequence (DALYNLPDLE tci arr tci ggi arr ttr tai ari gcr tc). PCR was performed in two stages on a robocycler Gradient 40 thermal cycler (Stratagene, La Jolla, CA, USA) using Taq DNA polymerase and dNTPs from Perkin-Elmer (Norwalk, CT, USA). Both stages were cycled 25 times with 30 s at 958C, 1 min at the annealing temperature, and 2 min at 728C. Three separate annealing temperatures (508C, 548C, and 588C) were run in parallel and a set without the degenerate primer was used as a control. The reactions were hot started and not allowed to cool below 728C between the stages. In the ®rst stage, 10-mL reactions containing 0.1 mm vector primer (ACCATGATTACGCCAAG), 0.1 mm degenerate primer, 100 mm dNTPs and 0.1 mL of library were hot started with 0.1 units of Taq in 0.5 mL of reaction buffer. In the second stage, 50 mL of prewarmed (728C) reaction mix containing 1-mm nested vector primer (GAAATTAACCCTCACT AAAGG), 1-mm degenerate primer and 100-mm dNTPs was added to each tube, then hot started again with 1 unit of Taq. The results of the PCR were assessed using agarose gel electrophoresis and the highest temperature reactions showing signi®cantly more product than the matched degenerate primerless control were PEG precipitated and TA cloned (Invitrogen, Carlsbad, CA, USA). Insert bearing clones were identi®ed using colony PCR then cycle sequenced by dye termination (Perkin Elmer, Norwalk, CT, USA). Inserts from promising degenerate clones were isolated and labeled using [ 32 P]dCTP and random primers (NEB, Beverly, MA, USA). These probes were then used to screen the library to identify full-length clones. Three clones were sequenced to generate a consensus. Sequence alignments were generated using Geneworks V2.1 and consensus contigs were assembled manually.
Northern blot analysis
Northern analysis was performed as previously described Fujisawa et al. 1999) . Ganglia were dissected and pooled from ®ve animals anesthetized with 50% volume of isotonic MgCl 2 . The RNA was isolated by the acid phenol method (Chomczynski and Sacchi 1987) . RNA was fractionated on a MOPS/formaldehyde 1.5% agarose gel and downward transferred (Turboblotter, Schleicher and Schuell, Keene, NH, USA) overnight with 20 Â SSPE (saline±sodium phosphate±EDTA) onto positively charged nylon (Biodyne B, Life Technologies, Gaithersberg, MD, USA). The RNA was UV cross-linked (Stratalinker, Stratagene, La Jolla, CA, USA) then washed with DEPC-treated water and stained with methylene blue (0.2% methylene blue 0.3 m sodium acetate, pH 5.5). The blot was scanned to document the loading and transfer of the RNA, and then the positions of the lanes and the bands in the RNA marker lane (Novagen, Madison, WI, USA) was noted on the membrane with a No. 2 pencil. Following complete destaining in 1% sodium dodecyl sulfate (SDS) 0.1 Â SSPE, the blots were prehybridized (50% formamide, 7% SDS, 250 mm sodium phosphate pH 7.2, 10 mm EDTA, 10% dextran sulfate) for 1 h at 508C in a rotary oven (Hybaid, Franklin, MA, USA). The blot was then hybridized with random primer labeled (NEB, Beverly, MA, USA) probe overnight at 508C. Washes were performed 2 Â 15 min at room temperature with 2 Â SSPE 0.1% SDS, then at 508C for 1 h with 0.1 Â SSPE 0.1% SDS. Blots were wrapped in cling ®lm and exposed to ®lm. Autoradiograms were aligned with the blots and the positions of the markers were noted. They were then scanned and assembled into ®nal ®gures using Photoshop 3.0.
Antibodies
The antigen was prepared, as previously described Fujisawa et al. 1999) , by coupling Aplysia cerebrin (NGGTADALYNLPDLEKIa) to bovine serum albumin (BSA; SIGMA A0281) using either EDC (1-ethyl-3-(dimethylaminopropyl) carbodiimide, SIGMA E7750) or Pf/G (paraformaldehyde/ glutaraldehyde ± EM Sciences, Fort Washington, PA, USA). The coupling was performed in a 0.5-mL volume of 50 mm NaH 2 PO 4 pH 7.2 containing 5 mg of BSA, 1 mg of peptide and either 10 mg of EDC or 1% paraformaldehyde and 0.1% glutaraldehyde. The mixture was allowed to react overnight at 48C and then the coupled antigen was puri®ed from the reaction using a Microcon-30 (spinning at 13 800 g for 30 min at 48C to concentrate). After washing the retentate 4 Â with 0.4 mL of 50 mm NaH 2 PO 4 pH 7.2, it was resuspended in 0.25 mL of the same buffer and transferred to a new tube.
Two male Sprague±Dawley rats (Teconic, 250±300 g) were immunized by intraperitoneal injection with 12.5 mL (ca. 250 mg) antigen in an emulsion of 0.5 mL phosphate-buffered saline (PBS) and 0.5 mL of Freunds complete adjuvant. At 21 days and 42 days post initial injection, the rats were boosted by intraperitoneal injection with 6.65 mL (,125 mg) antigen in an emulsion of 0.5 mL PBS and 0.5 mL of Freunds incomplete adjuvant. The animals were sacri®ced by decapitation at 49 days post initial injection, the blood harvested and processed for serum. Sera were aliquoted, frozen and lyophilized, or stored at 48C with EDTA (25 mm ®nal) and thimerosal (0.1% ®nal) added as stabilizers. Antibodies raised in both rats produced identical results.
A. californica immunocytochemistry
Immunocytochemistry was performed as previously described . Tissues were ®xed in freshly prepared ®xative (4% paraformaldehyde, 0.2% picric acid, 25% sucrose, 0.1 m NaH 2 PO 4 pH 7.6) either 3 h at room temperature or overnight in the cold. Following washes with PBS to remove the ®xative, the ganglia from large animals were de-sheathed to expose the neurons. All subsequent incubations were done at room temperature with rocking. Tissue was permeabilized and blocked by overnight incubation in BB (block buffer: 10% normal donkey serum, 2% Triton X-100, 1% BSA, 154 mm NaCl, 10 mm Na 2 HPO 4 , 50 mm EDTA, 0.01% thimerosal pH 7.4). Primary antibody was diluted 1 : 250 in BB and incubated with the tissue for 4±7 days. The tissue was then washed twice a day for 2±3 days with WB (wash buffer: 2% Triton X-100, 1% BSA, 154 mm NaCl, 10 mm Na 2 HPO 4 , 50 mm EDTA, 0.01% thimerosal pH 7.4). Following the washes, the tissue was incubated with 1 : 500 dilution of secondary antibody (Lissamine Rhodamine Donkey anti-Rat ± Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 2±3 days. Tissue was then washed twice with WB for 1 day and four times with SB (storage buffer: 1% BSA 154 mm NaCl, 10 mm Na 2 HPO 4 , 50 mm EDTA, 0.01% thimerosal pH 7.4) for 1 day. The tissues were then stored at 48C or viewed and photographed on a Nikon microscope (Morrell Institute Co., Melville, NY, USA) equipped with epi¯uorescence. Antibody speci®city was tested by preincubating the antibody with 10 24 m cerebrin. This preincubation abolished staining. No staining was detected when the secondary antibody was applied alone.
L. stagnalis immunocytochemistry
Central nervous system samples from seven L. stagnalis were stained. Following dissection, the CNS samples were treated for 1 h in 0.25% protease (type XIV) in physiological saline (pH 7.6 containing 44 mm NaCl, 1.7 mm KCl, 4 mm CaCl 2 1.5 mm MgCl 2 and 10 mm HEPES) and processed as whole mounts for immunocytochemistry as previously described (Croll and Chiasson 1989) with several modi®cations. The CNS were ®xed overnight at 48C with 4% paraformaldehyde in PBS (50 mm Na 2 HPO 4 , 140 mm NaCl, pH 7.2) and washed for 24 h with 4% Triton X-100 in PBS. For immunostaining, the ®xed tissue was preincubated in antibody diluent (PBS with 1.0% normal goat serum, 1.0% BSA and 0.5% Triton X-100) for 1 hour and then incubated for 72 h in primary antibody diluted 1 : 250 in the same antibody diluent. After 24 h rinses in PBS with 0.5% Triton X-100, the tissue was incubated for 1 h in antibody diluent and then overnight in Rodhamine X-Red goat anti-rat secondary antibody (Jackson ImmunoResearch) diluted 1 : 500 in antibody diluent. Tissues were rinsed for 24 h in PBS. All the preparations were dehydrated in a series of ethanol washes: 50%, 70%, 90%, 96% ethanol (1 Â 30 min) and 100% ethanol (2 Â 30 min) and then cleared in methyl salicylate and mounted in Permount. Viewing and photographing the stained tissue was performed using either an inverted microscope (IMT; Olympus, Melville, NY, USA) equipped with¯uorescence illumination or a confocal laser scanning microscope (LSM 210, Carl Zeiss, Thornwood, NY, USA).
In situ hybridization Whole mount in situ hybridization was performed as previously described (Fujisawa et al. 1999) . The tissues were pinned out in the desired orientation in 50% isotonic MgCl 2 /50% ASW. All subsequent reagents and solutions used in the in situ hybridization were made with diethyl pyrocarbonate treated MilliQ water. Tissues were ®xed in 4% paraformaldehyde, 0.5 m NaCl, 0.1 m MOPS (pH 7.5) for 3 h at RT or overnight at 48C, then washed for 3 Â 10 min at RT in PBT (0.8% NaCl, 0.02% KCl, 0.3% Na 2 HPO 4 -12H 2 O, 0.02% KH 2 PO 4 , 0.1% Tween-20, pH 7.4). The tissue was digested with 50 mg/mL of proteinase K in PBT for 30 min at 378C, then washed again with PBT for 3 Â 10 min at RT, post®xed with 4% paraformaldehyde in PBT for 1 h at RT, and washed for 3 Â 10 min at RT with PBT. The tissue was prehybridized for 1 h at 428C in hyb-buffer (5 Â SSC, 1% blocking reagent, 50 mg/mL salmon sperm DNA, 0.1% sarkosyl, 0.02% SDS) and then hybridized overnight at 428C in hyb-buffer containing 1 mg/mL of the labeled oligo. Two antisense oligos (CTGATAATCGCACGACACCG and GAACTCAGAGGATGG CGAGG) to the cerebrin mRNA were labeled by tailing with DIG-dUTP/dATP according to the manufacturer's instructions (Boehringer, Indianapolis, IN, USA). Unbound probe was washed out with 2 Â SSC/0.01% SDS for 3 Â 1 h at 428C then with PBT for 2 Â 10 min at RT. The tissue was blocked with 1% blocking reagent (Boehringer #1096176) in 0.15 m NaCl, 0.1 m maleic acid (pH 7.5) for 3 h at RT and then incubated in 1 : 200 dilution of anti-DIG antibody labeled with alkaline phosphatase (Boehringer #1093274) in blocking solution for 24 h at 48C. Unbound antibody was washed out with PBT for 5 Â 1 h at RT, then washed with detection buffer (0.1 m Tris, 0.1 m NaCl, 5 mm MgCl 2 , 10 mm levamisole) for 2 Â 30 min at RT. The signal was developed for 30 min at RT with detection buffer containing 350 mg/mL NBT, 175 mg/mL BCIP, and 0.1% Tween-20, and the reaction was then stopped by washing the tissue with PBT containing 1 mm EDTA (PBTE). The tissues were post®xed with 4% paraformaldehyde in PBT for overnight at 48C. After washing with PBT, they were stored protected from light in 50% glycerol, PBTE at 48C. Selected preparations were photographed on a Nikon microscope, the negatives scanned and compiled into ®gures with Photoshop 3.0.
Electrophysiology
Physiological activity of cerebrin was tested in a preparation that consisted of the isolated cerebral and buccal ganglia with cerebralbuccal connectives attached. Both ganglia were de-sheathed to expose the cells of interest. Conventional intracellular recordings were made with glass microelectrodes ®lled with 2 m KAc and beveled to 8±15 MV. Extracellular recordings were made with suction electrodes that were manufactured from polyethylene tubing. Ganglia were then pinned out in a Sylgard-coated dish that had a volume of ,1.5 mL. The preparation was continuously perfused with arti®cial seawater (ASW, composition: 460 mm NaCl, 10 mm KCl, 55 mm MgCl 2 , 11 mm CaCl 2 , and 10 mm HEPES buffer, pH 7.6) at a rate of 0.3 mL/min, and cooled to 14±178C. Peptides were applied by replacing the ASW perfusate with an ASW perfusate containing freshly dissolved peptides.
Results
MALDI MS experiments of the A. californica cerebral cluster have revealed the presence of several unidenti®ed peptides Rubakhin et al. 1999a Rubakhin et al. , 1999b in three distinct layers of the F-cluster. Speci®cally, MALDI MS of single middle (Fig. 1a) and bottom layer F-cluster neurons detected a peak with a mass of 1803 Da that did not correspond to any known neuropeptide. The same peak was also observed in the UL nerve (Fig. 1b) . Furthermore, F-cluster neurons have been observed to project to the UL nerve and ramify there in a manner consistent with neurohemal release (Rubakhin et al. 1999b) . Thus isolation and sequencing of the 1803-Da unknown peak was undertaken in an effort to identify potential neuroendocrine and neurohormone peptides in A. californica.
F-and C-clusters were pooled from 23 animals, homogenized, lyophilized, and subjected to three separate rounds of HPLC separation using MALDI MS to track the 1803-Da peptide. The result of the ®nal separation was a fraction with suf®cient amount and purity for peptide sequence analysis. The N-terminal sequencing analysis via Edman degradation revealed that the amino acid sequence of this peptide was: NGGTADALYNLPDLEKI. The mass of this peptide indicated that it was C-terminally amidated. Thus the sequence of the post-translationally modi®ed peptide was inferred to be: NGGTADALYNLPDLEKIa.
The amino acid sequence of cerebrin was used to design a degenerate oligonucleotide that was used in seminested PCR. This PCR yielded a single clone, which, upstream of the degenerate primer, encoded the predicted upstream amino acid sequence of cerebrin. Sequencing of the cDNA clones isolated by library screen generated a 683-bp consensus sequence (GenBank accession AF362572). Northern analysis (Fig. 2) indicates that the mRNA is approximately 800 bp in length suggesting that the clones isolated from the library were near full length. As shown in Fig. 3 , the mRNA of cerebrin consists of a 258-bp open reading frame which codes for an 86 amino acid precursor containing a single copy of the 1803-Da peptide.
When combined with the prohormone sequence, MALDI MS is a powerful tool to con®rm expected cleavage and determine unexpected processing steps, even at the single cell level (Jimenez et al. 1994; Garden et al. 1996 Garden et al. , 1998 Garden et al. , 1999 Li et al. 1998 Li et al. , 2000 . As the cells synthesizing cerebrin are easily isolated from the cerebral cluster (Rubakhin et al. 1999b) , individual cells were analyzed using MALDI MS and compared with MALDI MS analysis of HPLC fractions. More than 330 mass spectra from individual cell somas and nerves from over 40 A. californica have been examined. Mass spectrometric and biochemical characterization of each peptide are discussed separately below; in all cases, every measurement has been repeated numerous times and representative data are presented. The mass spectra shown in Fig. 1 are representative peptide pro®les from both a single middle layer F-cluster neuron and the UL nerve with the peptides described here labeled. Consistent with the targeting of the precursors to the release pathway, the precursor has a hydrophobic signal peptide. As shown in Fig. 1, a arising from the processing of proCerebrin is from the isolation, puri®cation and the sequencing of 23 amino acids from the N-terminus of this peptide, which matched the cerebrin prohormone exactly. The distribution of cerebrin in A. californica CNS was examined using immunocytochemistry and in situ hybridization (Fig. 4) . Comparison of the immunostaining and in situ hybridization staining patterns revealed the two match each other, e.g. Fig. 4(a1) versus Fig. 4(b1) , and Fig. 4(a2) versus Fig. 4(b2) , thus indicating that the antibodies are speci®c for cerebrin. In addition, the two staining patterns agreed with the results of the Northern analysis (Fig. 2) of cerebrin mRNA distribution. The mRNA distribution showed detectable levels only in the cerebral ganglia. Except for a single neuron in each pleural ganglion, and on each esophageal nerve (data not shown), all of the neuronal cell bodies that were positive for cerebrin were found in the cerebral ganglion. In the cerebral ganglion, cerebrin is present in a group of smaller middle and bottom layer F-and C-cluster neurons, three neurons in the A-and B-clusters, a group of neurons by the optic nerve, a neuron in the E-cluster, and a neuron in the M-cluster. All the stained neurons appeared to be bilaterally symmetrical.
A striking anatomical feature revealed by immunostaining is the dense branching of the cerebrin neurites throughout the UL nerve. This innervation forms a cuff that extends about half the length of the nerve and is consistent with neurohemal release area and consequent neuroendocrine function of cerebrin-producing neurons. Unlike the recently characterized AI that exhibited similar staining of the UL nerve, only a few neuronal processes in the AT nerve stained for cerebrin, while insulin stains the AT nerve intensely. Thus, the targeting of cerebrin to peripheral structures is different from that of AI.
Consistent with the localization of cerebrin to the neurohemal organ, this peptide was detected in A. californica hemolymph. MALDI MS analysis of separated hemolymph fractions indicated a peak containing a mass matching that of cerebrin (1803 Da). The retention time seen in the HPLC analysis closely matched to that of authentic cerebrin peptide isolated from the F-cluster. In addition, MALDI MS analysis of the cerebrin fraction following spiking with synthetic cerebrin resulted in a single peak having a mass of 1803 Da offering further proof of this assignment. The presence of cerebrin in hemolymph provides additional support to the hypothesis that this peptide has hormonal functions.
Cerebrin was also detected in connectives that link various ganglia. For instance, cerebrin immunostained axons are detected in the cerebral buccal connectives (CBCs, Fig. 4c ). Interestingly, using both MALDI MS Fig. 3 The cerebrin precursor sequence. In (a), the amino acids are numbered at right and cerebrin underlined. Dibasic cleavage sites con®rmed using MALDI are shown in bold. An asterisk denotes the signal sequence cleavage site. (b) Schematic of the cerebrin prohormone processing as con®rmed by MALDI and biochemical isolation of the peptides, showing the signal sequence, the two observed peptides, and basic residues marked with a line and dibasic with a bold line.
( Fig. 5b) and immunostaining, cerebrin was detected in the pleuroabdominal connectives of juvenile, but not adult, animals. Immunostaining of the nervous system revealed that cerebrin-like immunoreactivity was present in ®ne processes and varicosities in the neuropil of all the ganglia. A micrograph of immunostaining of cerebrin in the buccal ganglia is shown in Fig. 4(d) .
Because cerebrin immunostaining was detected both in the cerebral and buccal ganglia as well as in the connective that links the two ganglia, and these two ganglia jointly control feeding behavior (Kupfermann 1974a (Kupfermann , 1974b , we used ®ctive feeding motor programs to determine if cerebrin is bioactive. Speci®cally, we examined the effects of cerebrin on feeding motor programs induced by stimulation of the command-like neuron, CBI-2 (Rosen et al. 1991) . In these experiments, single two-phase cycles of motor programs were induced every 2 min by stimulating CBI-2 at 8±10 Hz with 10-ms current pulses. Induced motor programs consisted of a radula protraction phase followed by a radula retraction phase. As CBI-2 normally only ®res during protraction (Rosen et al. 1991) , we terminated the stimulation of CBI-2 as soon as protraction ended. Parametric features of motor programs are highly reproducible under these conditions, e.g. protractions and retractions have a consistent duration. Electrical activity in nerve I2 was used to monitor protraction because this nerve contains axons of protraction phase motor neurons B31/32 and B61/ 62 (Hurwitz and Susswein 1996; Hurwitz et al. 1996) . Electrical activity in the radula nerve, which contains axons of radula closer motorneuron B8, was used to monitor retraction phase because B8 is strongly active in retraction phase when the motor program is ingestive (Morton and Chiel 1993) .
The effects of cerebrin on motor programs elicited by CBI-2 stimulation are illustrated in Fig. 6 . Cerebrin had a dramatic effect on the duration of protraction; speci®cally, it shortened protraction duration. This shortening was concentration-dependent, i.e. the duration of protraction became progressively shorter as the concentration of cerebrin was increased. This is illustrated in Fig. 6(a) , which shows raw data for a single experiment. Group data are shown in Fig. 6(b) (n 4) . In Fig. 6(b) , protraction duration was expressed as a percentage of protraction duration`without peptide'. The`without peptide' value was the mean of protraction duration before and after peptide application. An overall statistically signi®cant difference between the different conditions was observed (anova, F 32.04; p , 0.001). When individual comparisons were made between different peptide concentrations and the no peptide condition, we found a statistically signi®cant decrease of protraction duration in the presence of 10 26 m and 10 25 m cerebrin (paired t-test, p , 0.05 for both comparisons; for both of the p-values, the Bonferroni correction for multiple comparisons was applied). Cerebrin did not produce a signi®cant difference in the duration of the retraction phase of the motor program. The perfusion of the preparation with several other peptides, e.g. APGWamide, did not shorten the protraction phase of the motor program. Thus, cerebrin exerted a highly speci®c action on the feeding motor program.
To determine whether cerebrin is speci®c to only one species of Aplysia, A. californica, or is also present in different species of Aplysia we investigated the presence of cerebrin in A. vaccaria. Although A. vaccaria is closely related to A. californica, it has a number of striking morphological differences. For instance, A. vaccaria does Feeding motor programs were elicited by a 9-Hz stimulation of CBI-2 (top trace of each set of four traces). High frequency discharges in the I2 nerve (third trace) were used to monitor the protraction phase. Discharges in the radula nerve (RN, last trace) were used to monitor retractions. B8 (second trace) is a radula closure motor neuron which ®res during retraction phase when the motor program is ingestive. B8 sends its axon to radula nerve. Shortening of protraction duration became greater when concentration of cerebrin was increased. (b) Group data summarizing the effects of cerebrin on the duration of protraction phase. Protraction duration is normalized as percentage of the mean of control and wash values.
not have the ink gland that is present in A. californica and is used to secrete purple ink in response to nociceptive stimuli. MALDI MS of individual neurons isolated from the cerebral ganglion F-cluster of A. vaccaria (Fig. 5a ) revealed a peak with a weight of 1803 Da matching cerebrin. HPLC puri®cation of this cluster following by MALDI MS analysis con®rmed that, by mass, this peptide is identical to the A. californica cerebrin.
In addition to being found in Aplysia species, cerebrinlike peptides are likely to be present in distantly related species of gastropods. Previously, we reported (Rubakhin et al. 1999b ) that the F-cluster neurons located in the cerebral ganglia in A. californica have similar appearance, position, and physiological properties to several neuronal clusters from the pulmonate L. stagnalis. For instance, insulin exists in the F-cluster of A. californica ) and the complementary light yellow cells of L. stagnalis. In L. stagnalis, cerebrin-like immunostaining was observed in 7±9 neurons of cerebral ganglia and in 1±2 neurons of the pedal ganglia. The soma sizes ranged from ,10 mm to ,50 mm, with the largest somata being in the cerebral ganglia. Immunoreactive ®bers ran through the neuropil of every ganglion and were seen to extend peripherally from cerebral ganglia through the opticotentacular and labial nerves and from the visceral ganglion. Immunoreactive ®bers were observed in cerebral commissure, cerebro-pleural, pleuro-parietal, viscero-parietal and cerebro-pedal connectives, with staining most prominent in the cerebral commissure. Although there are fewer cerebrin immunoreactive neurons in L. stagnalis than in A. californica and staining of ®bers in the cerebral nerves is less pronounced, the pattern of staining in the two species is similar (Fig. 7) .
Discussion
In this study we isolated, cloned, localized, and characterized a novel bioactive peptide cerebrin in A. californica.
Several criteria con®rm that the isolated clone represents the precursor of cerebrin that was originally isolated and sequenced from the F-and C-cluster neurons. First, the amino acid sequence of cerebrin is found on the precursor and is¯anked by dibasic processing sites, indicating it likely is proteolytically cleaved from the precursor (Seidah and Chretien 1999) . In addition, the C-terminal glycine, which, in the presence of PAM (peptidyl-glycine alpha-amidating monooxygenase), is converted to an amidated peptide (Eipper et al. 1992) . Both processing steps are con®rmed by MALDI MS that detected a mass of 1 Da less than the mass predicted for the non-amidated peptide. Second, the Northern analysis (Fig. 2) shows that the precursor mRNA is mostly localized in the cerebral ganglion, where the Fand C-clusters are located. Third, the antibody directed against the cerebrin peptide sequence stains neurons in the F-and C-clusters and the UL nerve (Fig. 4) . Furthermore, an additional peptide predicted by the precursor was observed in the MALDI MS spectra from these neurons (Fig. 1) .
The structure of the precursor revealed the presence of a signal sequence indicating that the precursor is targeted to the secretory pathway (Walter and Blobel 1981) . In addition to cerebrin, the precursor also predicts the 4215-Da peptide (V[28]±V[64] ). This mass corresponds to a peak in the MALDI spectrum obtained from single F-cluster neurons and to a mass observed in the neurohemal organ of the UL. Although we have not determined whether this peptide is bioactive, its transport to and persistence in a non-degraded form in the neurohemal organ suggests that it may be bioactive. Searches of PIR and SwissProt protein sequence databases indicate that both cerebrin and the 37 amino acid V[28]±V[64] peptide are not signi®cantly related to any previously characterized peptides or proteins.
Except for one neuron in each pleural ganglia and one in the esophageal nerves, all of the cerebrin-synthesizing neurons are located in the cerebral ganglia. In turn, within the cerebral ganglia most of the cerebrin-containing neurons are localized to the F-cluster. Axons of the F-cluster neurons projecting to the neurohemal release organ form a dense meshwork of ®ne processes and varicosities. Since cerebrin is detected in the hemolymph it is likely that cerebrin functions as a hormone. Cerebrin may also play a neuromodulatory role as is suggested by the presence of cerebrin-like immunostaining of ganglionic neuropil. Particularly revealing was the presence of staining in the neuropil of buccal ganglia and the presence of axonal immunostaining in the CBCs. Since no cerebrin-synthesizing cells were detected in the buccal ganglia, it is likely that the cerebrin immunopositive axons observed in the CBCs originate from the cerebral ganglia. Because a bilateral pair of cerebrincontaining cells were observed in the cerebral M-cluster, a cluster that contains several cerebral-buccal interneurons (CBIs) (Rosen et al. 1991) , it is possible that one of these CBIs contains cerebrin. The presence of cerebrin-like immunostaining in the neuropil, as well as axonal immunostaining of the CBCs, in which cerebrin staining did not reveal the presence of a neurohemal organ, suggests that cerebrin transported in the CBCs is destined to function as a local signaling molecule rather than as a hormone. Several signaling molecules have been shown to act both as hormones and local transmitter/modulators. For example, the endocrine hormones oxytocin and vasopressin have been shown to have local transmitter-like actions as well (Strand 1999) . As another example, Marder and co-workers demonstrated that in the STG circuit, proctolin acts both as a circulating hormone and a locally released modulator at different concentrations (Marder et al. 1986) .
The presence of cerebrin in the CBCs may have important physiological implications. Several lines of evidence indicate that the cerebral and buccal ganglia mediate the consummatory phase of feeding behavior. First, disconnecting the cerebral and buccal ganglia from each other abolishes the consummatory feeding responses (Kupfermann 1974b) . Second, the cerebral ganglion contains at least two neurons, CBI-2 and CBI-4 that are activated by food stimuli, project to the buccal ganglia, and upon stimulation can initiate feeding motor programs in the buccal ganglia (Rosen et al. 1991; Church and Lloyd 1994) . Since buccal motor programs can be elicited via electric stimulation in isolated buccal ganglia, these ganglia are thought to contain crucial elements of the feeding CPG (Susswein and Byrne 1988; Hurwitz et al. 1996 Hurwitz et al. , 1997 Nargeot et al. 1997; Kabotyanski et al. 1998 Kabotyanski et al. , 2000 . Thus, the cerebral ganglion is thought to initiate rhythmic buccal activity that sustains feeding behaviors. In addition to initiating feeding behaviors, it is likely that cerebral neurons modulate the characteristics of feeding as some of the CBIs have been shown to contain neuropeptides and application of these peptides to buccal ganglia modi®es the characteristics of feeding motor patterns (Morgan et al. 2000) . The serotonergic metacerebral cells (MCCs) that project to the buccal ganglia also modulate the buccal circuits (Weiss et al. 1975 (Weiss et al. , 1986 Kabotyanski et al. 2000; Morgan et al. 2000) . The presence of cerebrin in the CBCs and in one neuron from the M-cluster, the cluster that contains several CBIs, raised the possibility that cerebrin detected in the buccal neuropil may modulate buccal motor programs, and we found this to be the case.
Cerebrin exerted a characteristic action on motor programs that were evoked by stimulation of the command-like neuron CBI-2. Cerebrin signi®cantly shortened the protraction phase of the motor program, but left the retraction phase unchanged. Previous work has indicated that CBI-2 produces a speci®c class of ingestive behavior, the biting responses (Rosen et al. 1991; Church and Lloyd 1994; Sanchez and Kirk, 2000) . In feeding animals, one also observes a second category of feeding behaviors, namely the swallowing responses (Kupfermann 1974a) . A major difference between swallowing and biting is that the retraction phase is signi®cantly increased in swallowing behaviors (Cropper et al. 1990 ). Since cerebrin did not extend the retraction phase, it is likely that the motor patterns observed in the presence of cerebrin continue to represent biting, albeit with a shorter protraction phase. Previous studies demonstrated that protraction phase is shortened by the serotonergic MCCs and by neuropeptide CP2 that is contained in CBI-2 (Morgan et al. 2000) . Both of these effects along with some additional actions of these modulators have been implicated in the food-induced arousal state of the animal (Weiss et al. 1975 (Weiss et al. , 1986 Kupfermann and Weiss 1982; Rosen et al. 1989; Kabotyanski et al. 2000; Morgan et al. 2000) . The MCC is an extrinsic modulator, while CP2 contained in neuron CBI-2 is an intrinsic modulator of feeding circuitry. At this time we do not know whether cerebrin acts as an intrinsic or extrinsic modulator, or for that matter whether it acts on the cerebral or buccal ganglia as we applied cerebrin to both ganglia. Irrespective of its site of action, the presence of cerebrin in the buccal ganglia and the fact that cerebrin can be released into the circulation raises the question which of the two sources of cerebrin are carrying out the actions that were observed in response to application of exogenous cerebrin. It is attractive to speculate that under different behavioral circumstances distinct sources of cerebrin might be operational. If hormonally released cerebrin can indeed affect the motor program, this would add a new dimension to the already characterized intrinsic and extrinsic modulation of protraction-phase duration, each of which has a unique set of characteristics that appear to act to increase the ef®ciency of feeding behavior.
Cerebrin is present not only in Aplysia californica. Similarity of cellular distribution, the same HPLC retention time, and mass identity indicates cerebrin sequence identity between A. californica and A. vaccaria. This strongly suggests a selective pressure to conserve the sequence of cerebrin. For example, the nine-residue a-bag cell peptide is identical between the two species, the 36 amino acid residue egg-laying hormone has six differences in sequence, and acidic peptide, with no assigned biological function, has a much greater heterogeneity . Our data indicate that a cerebrin-like peptide is present not only in opisthobranchs (Aplysia), but also in the sister taxa, pulmonates (Lymnaea). As Lymnaea and Aplysia are evolutionarily distant, the presence of cerebrin-like peptides in both of them suggests that this peptide may be widespread amongst the gastropods. In addition to a neurohormonal role, a peptidergic transmission role is indicated; in both species, staining was observed in the neuropil of every ganglion where synaptic transmission is believed to occur. Overall, our data on A. californica and L. stagnalis suggest that cerebrin and cerebrin-like molecules may play similar roles in both species. Thus cerebrin and related peptides may be present in many gastropods and possibly other species as well.
